Vaccination considerations for patients with inflammatory bowel disease

Practical Gastroenterology

Volumn 35, Issue 4, 2011, Pages 33-40

  Boroujerdi Rad, Laleh ^a   Melmed, Gil Y ^b,c  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOMODULATING AGENT; INFLIXIMAB; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; MERCAPTOPURINE; PNEUMOCOCCUS VACCINE; PREDNISONE; TUMOR NECROSIS FACTOR INHIBITOR; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE;

ANTIVIRAL THERAPY; ARTICLE; CROHN DISEASE; DIPHTHERIA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG SAFETY; ENTERITIS; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VACCINATION; INFORMATION DISSEMINATION; LIVER FAILURE; LOW DRUG DOSE; MEASLES; MEASLES VACCINATION; MENINGOCOCCOSIS; MUMPS; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PERTUSSIS; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; RISK BENEFIT ANALYSIS; RISK FACTOR; RUBELLA; SEROCONVERSION; TETANUS; TREATMENT RESPONSE; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX DYSPLASIA; VACCINATION; VIRUS REACTIVATION; VIRUS TRANSMISSION;

EID: 80052484686     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Lu Y, Jacobson D, Bousvaros A. Immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1417-1423.2.
2. Toruner M, Loftus Jr E, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterol 2008;134:929-936.
3. Ritz MA, Jost R. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease. Inflamm Bowel Dis 2001;7:327.
4. Leung VS, Nguyen MT, Bush TM. Disseminated primary varicella after initiation of infliximab for Crohn's disease. Am J Gastroenterol 2004;99:2503-4.
5. Esteve M, Saro C, Gonzalez-Huix F, Suarez F, Forne M, Viver JM. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 2004;53:1363-5.
6. Melmed GY, Ippoliti AF, Papadakis KA, Tran TT, Birt JL, Lee SK, Frenck RW, Targan SR, Vasiliauskas EA. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 2006;101:1834-40.
7. Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol 2010;105:1231-1238.
8. Leung VS, Nguyen MT, Bush TM. Disseminated primary varicella after initiation of infliximab for Crohn's disease. Am J Gastroenterol 2004;99:2503-4.
9. Sands BE, Cuffari C, Katz J, Kugathasan S, Onken J, Vitek C, Orenstein W. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:677-692.
10. Melmed GY, Agarwal N, Frenck RW, Ippoliti AF, Ibanez P, Papadakis KA, Simpson P, Barolet-Garcia C, Ward J, Targan SR, Vasiliauskas EA. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol 2010;105:148-54.
11. Kotton CN. Vaccines and inflammatory bowel disease. Dig Dis 2010;28:525-35.
12. Wasan SK, Coukos J, Farraye FA. Gastroenterologist (GI) knowledge and behavior in vaccinating the inflammatory bowel disease (IBD) patient. Gastroenterol 2010;138:S-534.
13. Yeung J, Fedorak RN, Goodman KJ. Gastroenterologists and patients have inadequate immunization knowledge which subsequently may lead to increased infection risk in immunocompromised IBD patients. Gastroenterol 2010;138: S-523.
14. Center for disease control and prevention: Prevention and control of influenza with vaccines, 2010. Morbidity and Mortality Weekly Report. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr59e0729a1.htm?s_cid=rr59e0729a1_w (accessed 1/3/11).
15. Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:851-6.
16. Lu Y, Jacobson DL, Ashworth LA, Grand RJ, Meyer AL, McNeal MM, Gregas MC, Burchett SK, Bousvaros A. Immune Response to Influenza Vaccine in Children With Inflammatory Bowel Disease. Am J Gastroenterol 2009.
17. ACIP website: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5515a1.htm.
18. DeStefano F, Goodman RA, Noble GR, McClary GD, Smith SJ, Broome CV. Simultaneous administration of influenza and pneumococcal vaccines. JAMA 1982;247:2551-4.
19. CDC Website: http://www.cdc.gov/hepatitis/Resources/Professionals/PDFs/ABCTable.pdf
20. Radzikowski A, Banaszkiewicz A, Lazowska-Przeorek I, Grzybowska-Chlebowczyk U, Wos H, Pytrus T, Iwanczak B, Kowalska-Duplaga K, Fyderek K, Gawronska A, Karolewska-Bochenek K, Kotowska M, Albrecht P. Immunogenecity of hepatitis A vaccine in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2010.
21. Shale MJ, Seow CH, Coffin CS, Kaplan GG, Panaccione R, Ghosh S. Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease. Aliment Pharmacol Ther 31:20-34.
22. Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use-Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2010;59:273.
23. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55:1-48.
24. Melmed GY. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis 2009;15:1410-6.
25. California Department of Public Health Website: http://www.cdph.ca.gov/programs/immunize/Documents/PertussisReport2010-12-15.pdf
26. Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol 2008;103:631-6.
27. Lu Y, Bousvaros A. Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy. J Pediatr Gastroenterol Nutr 2010;50:562-5.
28. CDC Website: Recommendations of the Advisory Committee on Immunization Practices (ACIP). http://www.cdc.gov/mmwr/pdf/rr/rr5705.pdf. Accessed June6, 2008.
29. Marin M, Guris D, Chaves SS, Schmid S, Seward JF: Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2007;56:1-40.
30. Harpaz R, Ortega-Sanchez IR, Seward JF: Prevention of herpes zoster: recommmendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2008;57:1-30.
31. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW, Jr., Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecker R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-2284.
32. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57:1-30.
33. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55:1-48.
34. Watson JC, Hadler SC, Dykewics CA et al. Measles, mumps, rubella-vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998;47:1-57.
35. Kamboj, M, Sepkowitz KA. Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient. Infec Control Hosp Epidemiol; 2007:28:702-707.